Immunic
IMUX
29 hedge funds and large institutions have $50.9M invested in Immunic in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 6 closing their positions.
9% less funds holding
Funds holding: 32 → 29 (-3)
24% less capital invested
Capital invested by funds: $67.1M → $50.9M (-$16.2M)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.27M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$973K |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
+$604K |
| 4 |
State Street
Boston,
Massachusetts
|
+$151K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$85K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$689K |
| 2 |
Jane Street
New York
|
-$540K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$258K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$208K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$198K |
IMUX Hedge Fund Activity: Q3 2014 in Review
29 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2014, worth a combined $50.9M — down 24% from $67.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IMUX and 3 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $1.27M. The largest seller was Tudor Investment Corp, exiting entirely with an estimated $689K sold.
- 29 institutional investors held Immunic (IMUX) as of Q3 2014, down from 32 in Q2 2014.
- Funds reported $50.9M of Immunic stock for Q3 2014, down 24% quarter-over-quarter.
- 3 funds opened new Immunic positions in Q3 2014 and 6 closed out, a net change of -3 holders.
- The largest Immunic buyer in Q3 2014 was Vanguard Group, an estimated $1.27M added.
- The largest Immunic seller in Q3 2014 was Tudor Investment Corp, an estimated $689K sold.
Based on aggregated 13F filings for Q3 2014.